Breaking News, Financial News

Financial Report: PPD 3Q

Clinical Development Services revenue was $260.3 million in the quarter (+4%).

PPD 3Q

3Q Revenues: $365.4 million (+7%)

3Q Earnings: $38.0 million (+1%)

YTD Revenues:
$1.1 billion (+2%)

YTD Earnings: $76.2 million (earnings were $140.3 million YTD09)

Comments: Clinical Development Services revenue was $260.3 million in the quarter (+4%). Lab Services revenue was up 17% to $79.0 million. Backlog at September 30, 2010 was $3.4 billion. Contract cancellations and adjustments were $220.9 million in the quarter, including two project cancellations totaling $92.8 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters